Lupus & Connective Tissue Diseases
Conference Coverage
VIDEO: Don’t rely on ANCA to diagnose primary vasculitis
Conference Coverage
Tabalumab development for lupus stops because of mixed phase III results
Key clinical point: Phase III trials for tabalumab in systemic lupus erythematosus yielded mixed results for efficacy and safety.
News
First-line ambrisentan plus tadalafil halved PAH events
Key clinical point: First-line combination therapy with ambrisentan plus tadalafil cut the rate of clinical events in pulmonary arterial...
News
New IPF guidelines limit treatment choices
Conference Coverage
EULAR: Panel targets six rheumatic disease comorbidities
Conference Coverage
Counseling key to guiding rheumatic disease treatment during pregnancy
Conference Coverage
EULAR: Updated scleroderma guidance focuses on new treatments, approaches
News
Pregnancy outcomes better than expected in SLE
Key clinical point: Pregnancy outcomes were better than expected in the largest study to date of pregnant women with SLE. Major finding: Overall,...
News
Early nonadherence ups emergency care, hospitalization for lupus
Key clinical point: Early nonadherence among new SLE drug users could represent an opportunity to intervene to reduce acute morbidity and health...
Conference Coverage
VIDEO: Assessment tool rapidly screens lupus cognition
Conference Coverage
Uncomplicated pregnancies in women with lupus may not boost risk for CV events
Key clinical point: An uncomplicated pregnancy doesn’t appear to accelerate the risk of cardiovascular events in women with systemic lupus...